drugset / Trial / NCT00093288

Major Depressive Disorder In The Elderly

NCT00093288

Phase 3 Completed 364 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a placebo-controlled study evaluating the effectiveness of medication in elderly subjects with Major Depressive Disorder (MDD).

Timeline

Start
2004-06
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 150 mg
Subject Bupropion Small molecule 300 mg